The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care - Australia
doi 10.1177/0310057x0603400115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research
2012English

Recombinant Activated Factor VII and Aortic Surgery

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery
2012English

Successful Management of Severe Bleeding After Redo Cardiac Transplantation With Recombinant Activated Factor VII

Journal of Clinical Case Reports
2012English

Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2009English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis
Hematology
2001English

Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report

Cases Journal
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy